Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Monte Rosa Therapeutics Inc (GLUE)

Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Monte Rosa Therapeutics Inc 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118 USA

www.monterosatx.com Employees: 133 P: 617-949-2643

Description:

Monte Rosa Therapeutics Inc. is a biotechnology company. It involved in developing a portfolio of novel small molecule precision medicines which employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. Monte Rosa Therapeutics Inc. is based in BOSTON.

Key Statistics

Overview:

Market Capitalization, $K 513,613
Enterprise Value, $K 385,513
Shares Outstanding, K 61,437
Annual Sales, $ 0 K
Annual Net Income, $ -135,350 K
Last Quarter Sales, $ 9,220 K
Last Quarter Net Income, $ -23,860 K
EBIT, $ -128,980 K
EBITDA, $ -122,760 K
60-Month Beta 1.30
% of Insider Shareholders 6.50%
% of Institutional Shareholders 79.96%
Float, K 57,444
% Float 93.50%
Short Volume Ratio 0.39

Growth:

1-Year Return 180.20%
3-Year Return -59.32%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.29 on 11/07/24
Next Earnings Date 11/14/24
Earnings Per Share ttm -1.83
EPS Growth vs. Prev Qtr 32.56%
EPS Growth vs. Prev Year 58.57%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

GLUE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -62.68%
Return-on-Assets % -38.84%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales 37.75
Price/Cash Flow N/A
Price/Book 2.48
Book Value/Share 3.35
Interest Coverage -3.21
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar